,questions in daily urologic practice (2008) springer publications

1
Book Review Questions in Daily Urologic Practice Springer Publications 2008 This handbook discusses various uropathology issues that we come across in our day-to-day life. It is primarily written by 2 pathologists, R. Oyasu and X.J. Yang from Northwestern University, Chicago, Illinois, with contri- butions from a Japanese Urologist, O. Yoshida. Even though the primary authors are pathologists, references have been taken equally from both urology and pathology articles. This book attempts to answer various questions in the practice of uro-oncology. Because the pathologist’s role in urology is mainly in oncology, only oncology-related issues are addressed. The questions-and-answers format is very interesting, with detailed comments and references. Reading the questions and answers alone is enough to get the take-home message. In the evidence-based era, to substantiate the answers we need a back up from pub- lished studies. The evidence part is described in detail in the “Comment” section, with appropriate illustrations and references. As we know, major research is done and maximum publications are seen in prostate cancer. Every year in The American Urological Association and European As- sociation of Urology meetings, newer updates are added more in prostate cancer than in any other area. This book also dedicates one third of its volume to prostate cancer. The remaining pages discuss adrenal, renal, bladder, and testicular cancers. Penile cancer is left out because of its decreasing incidence in the Western world. Few questions not answered by the standard textbooks are answered in this book, for example, importance of tertiary Gleason’s score in prostate cancer and deficien- cies in the 2002 TNM/AJCC staging of renal cell carci- noma. 1 In few questions with ambiguity, both the con- trast views are answered with references, enabling the reader to select their options, for example, presence or absence of prostatic capsule and importance of perineural invasion in prostate cancer. Few issues that still need further support from published data have been truthfully left unanswered, such as the research question, “Is Pros- tate cancer involving sphincter still pT2 or pT3?” The authors also have many of their own contribution to uropathology, such as molecular classification of type 2 papillary RCC into types 2 A and 2 B. 2 I conclude by saying that this book is a must read for all those preparing for postgraduate examinations. A consid- erable amount of information they obtain by wide search- ing is concentrated in this single handbook. This is a good reference book for practicing urologists to face a well-read colleague from pathology branch and to talk in “Pathological” language. It is a well-updated book for all pathologists practicing uropathology. If you present this book to your pathologist– 1. You will be thanked immensely, 2. You will obtain better evidence-based pathology re- ports, and 3. You will, in turn, give evidence-based treatment to your patient—the ultimate aim of all research work in this world. References 1. Leibovich BC, Cheville JC, Lohse CM, et al. Cancer specific sur- vival for patients with pT3 renal cell carcinoma: can the 2002 primary tumor classification be improved? J Urol. 2005;173:716-719. 2. Yang XJ, Tan MH, Kim HL, et al. A molecular classification of papillary renal cell carcinoma. Cancer Res. 2006;65:5628-5637. Ananda Kumar, M.B.B.S., D.N.B., M.R.C.S. From the Department of Urology, Vedanayagam Hospital, Coim- batore, Tamil Nadu, India doi:10.1016/j.urology.2009.04.044 © 2009 Elsevier Inc. 0090-4295/09/$34.00 713 All Rights Reserved

Upload: ananda-kumar

Post on 30-Oct-2016

212 views

Category:

Documents


0 download

TRANSCRIPT

QS

TwwNbtha

piivRtslta

pTsmaTtd

atcnt

©A

Book Reviewraiflt

tp

teigw“p

12

3

R1

2

ADb

uestions in Daily Urologic Practicepringer Publications 2008

his handbook discusses various uropathology issues thate come across in our day-to-day life. It is primarilyritten by 2 pathologists, R. Oyasu and X.J. Yang fromorthwestern University, Chicago, Illinois, with contri-

utions from a Japanese Urologist, O. Yoshida. Evenhough the primary authors are pathologists, referencesave been taken equally from both urology and pathologyrticles.

This book attempts to answer various questions in theractice of uro-oncology. Because the pathologist’s rolen urology is mainly in oncology, only oncology-relatedssues are addressed. The questions-and-answers format isery interesting, with detailed comments and references.eading the questions and answers alone is enough to get

he take-home message. In the evidence-based era, toubstantiate the answers we need a back up from pub-ished studies. The evidence part is described in detail inhe “Comment” section, with appropriate illustrationsnd references.

As we know, major research is done and maximumublications are seen in prostate cancer. Every year inhe American Urological Association and European As-

ociation of Urology meetings, newer updates are addedore in prostate cancer than in any other area. This book

lso dedicates one third of its volume to prostate cancer.he remaining pages discuss adrenal, renal, bladder, and

esticular cancers. Penile cancer is left out because of itsecreasing incidence in the Western world.Few questions not answered by the standard textbooks

re answered in this book, for example, importance ofertiary Gleason’s score in prostate cancer and deficien-ies in the 2002 TNM/AJCC staging of renal cell carci-oma.1 In few questions with ambiguity, both the con-

rast views are answered with references, enabling the

2009 Elsevier Inc.ll Rights Reserved

eader to select their options, for example, presence orbsence of prostatic capsule and importance of perineuralnvasion in prostate cancer. Few issues that still needurther support from published data have been truthfullyeft unanswered, such as the research question, “Is Pros-ate cancer involving sphincter still pT2 or pT3?”

The authors also have many of their own contributiono uropathology, such as molecular classification of type 2apillary RCC into types 2 A and 2 B.2

I conclude by saying that this book is a must read for allhose preparing for postgraduate examinations. A consid-rable amount of information they obtain by wide search-ng is concentrated in this single handbook. This is aood reference book for practicing urologists to face aell-read colleague from pathology branch and to talk in

Pathological” language. It is a well-updated book for allathologists practicing uropathology.If you present this book to your pathologist–

. You will be thanked immensely,

. You will obtain better evidence-based pathology re-ports, and

. You will, in turn, give evidence-based treatment toyour patient—the ultimate aim of all research work inthis world.

eferences. Leibovich BC, Cheville JC, Lohse CM, et al. Cancer specific sur-

vival for patients with pT3 renal cell carcinoma: can the 2002primary tumor classification be improved? J Urol. 2005;173:716-719.

. Yang XJ, Tan MH, Kim HL, et al. A molecular classification ofpapillary renal cell carcinoma. Cancer Res. 2006;65:5628-5637.

nanda Kumar, M.B.B.S., D.N.B., M.R.C.S. From theepartment of Urology, Vedanayagam Hospital, Coim-atore, Tamil Nadu, India

doi:10.1016/j.urology.2009.04.044

0090-4295/09/$34.00 713